| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Halma plc (LSE: HLMA)
HLMA Technical Analysis
5
| As on 20th Dec 2024 HLMA STOCK Price closed @ 2725.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2165.18 & Strong Buy for SHORT-TERM with Stoploss of 2124.05 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HLMASTOCK Price
| Open | 2710.00 | Change | Price | % |
| High | 2735.00 | 1 Day | -8.00 | -0.29 |
| Low | 2690.71 | 1 Week | -69.00 | -2.47 |
| Close | 2725.00 | 1 Month | 187.00 | 7.37 |
| Volume | 1011390 | 1 Year | 513.00 | 23.19 |
| 52 Week High 2809.00 | 52 Week Low 1810.50 | ||||
LSE UK Most Active Stocks
| TRP | 0.04 | % |
| LLOY | 54.20 | -0.18% |
| DKE | 0.15 | 0.00% |
| ORCP | 0.02 | -33.33% |
| NNN | 0.09 | 50.00% |
| DMTR | 0.03 | 0.00% |
| BOIL | 0.08 | 0.00% |
| VOD | 66.50 | -0.84% |
| MCLS | 1.68 | 46.09% |
| DIS | 0.12 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| HLMA Daily Charts |
HLMA Intraday Charts |
Whats New @ Bazaartrend |
HLMA Free Analysis |
|
|
HLMA Important Levels Intraday
| RESISTANCE | 2810.35 |
| RESISTANCE | 2782.98 |
| RESISTANCE | 2766.06 |
| RESISTANCE | 2749.14 |
| SUPPORT | 2700.86 |
| SUPPORT | 2683.94 |
| SUPPORT | 2667.02 |
| SUPPORT | 2639.65 |
HLMA Forecast December 2024
| 4th UP Forecast | 3220.24 |
| 3rd UP Forecast | 3061.41 |
| 2nd UP Forecast | 2963.24 |
| 1st UP Forecast | 2865.07 |
| 1st DOWN Forecast | 2584.94 |
| 2nd DOWN Forecast | 2486.76 |
| 3rd DOWN Forecast | 2388.59 |
| 4th DOWN Forecast | 2229.76 |
HLMA Weekly Forecast
| 4th UP Forecast | 2933.12 |
| 3rd UP Forecast | 2866.37 |
| 2nd UP Forecast | 2825.12 |
| 1st UP Forecast | 2783.86 |
| 1st DOWN Forecast | 2666.14 |
| 2nd DOWN Forecast | 2624.88 |
| 3rd DOWN Forecast | 2583.63 |
| 4th DOWN Forecast | 2516.88 |
HLMA Forecast2024
| 4th UP Forecast | 4677.05 |
| 3rd UP Forecast | 4051.02 |
| 2nd UP Forecast | 3664.05 |
| 1st UP Forecast | 3277.09 |
| 1st DOWN Forecast | 2172.92 |
| 2nd DOWN Forecast | 1785.95 |
| 3rd DOWN Forecast | 1398.98 |
| 4th DOWN Forecast | 772.95 |
Halma plc ( LSE UK Symbol : HLMA )
Sector : Industrials And Other Stocks in Same Sector
Sector : Industrials And Other Stocks in Same Sector
HLMA Business Profile
Halma plc provides technology solutions in the safety, health, and environmental markets. It operates through four segments: Process Safety, Infrastructure Safety, Environmental & Analysis, and Medical. The Process Safety segment offers specialized interlocks that control critical processes safely; instruments that detect hazardous gases; and explosion protection and corrosion monitoring systems. This segment serves the gas detection, industrial access control, pressure management, and safe storage and transfer markets. The Infrastructure Safety segment provides fire detection systems, specialist fire suppression systems, elevator safety systems, people and vehicle flow technologies, and security sensors. It serves the fire detection and suppression, People and Vehicle Flow, Security Sensors, and elevator markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and Original Equipment Manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom. Address: Misbourne Court, Amersham, United Kingdom, HP7 0DE
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service